1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Chronic Limb-Threatening Ischemia: new trials by email Literature Review of Chronic Limb-Threatening Ischemia trials Research Report on Chronic Limb-Threatening Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) BGC101 (autologous EnEPC preparation), Control medium - Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease | Phase 1 / Phase 2 | Active not recruiting | BioGenCell Ltd. | 40 | 2016-06-01 | 2025-06-06 |
Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1)
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Ischemia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
BioGenCell Ltd. (1)
Israel (1) · United States (1)
Alexander Reyzelman, MD (1) · Alisha Oropallo, MD (1) · Caitlin Hicks, MD (1) · Edouard Aboian, MD (1) · Igor Laskowski, MD (1) · Jeffrey J Siracuse, MD (1) · Khanjan Nagarsheth, MD (1) · Mark Wyers, MD (1) · Michael Conte, MD (1) · Moshe Halak, MD (1) · Nathalie Moreels, MD (1) · Paata Meshveliani, MD (1) · Shlomo J Baytner, MD (1) · Tony Karram, MD (1)